Skip to main content
Clinical Trials/EUCTR2016-002223-28-FR
EUCTR2016-002223-28-FR
Active, not recruiting
Phase 1

Tau brain imaging in typical and atypical Alzheimer’s Disease (AD) - TEPTA

CHRU DE TOURS0 sites24 target enrollmentNovember 30, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
CHRU DE TOURS
Enrollment
24
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 30, 2016
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Age \= 50 years
  • \- Native language: French
  • \- Studies level \= 7 years (considering as a starting point in the first year of primary education)
  • \- Correct sensory capabilities (hearing aids accepted) to perform the tests
  • \- Affiliation to the social security system,
  • \- Informed Consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials